02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
Just before the Labor Day holiday, the Mine Safety and Health Administration published a long-expect...
Read More >
WASHINGTON -- The U.S. Equal Employment Opportunity Commission (EEOC) today announced the newest edi...
Read More >
Hotels in New Jersey will soon be required to provide panic buttons for employees who work in guest ...
Read More >
Employers are struggling to determine how to respond to the 2019 novel coronavirus (2019-nCoV) outbr...
Read More >
U.S. Citizenship & Immigration Services (USCIS) confirmed it will utilize a new electronic registrat...
Read More >
The Development: The U.S. Department of Justice ("DOJ") and a divided Federal Trade Commission ("FTC...
Read More >